StockMarketWire.com - C4X Discovery said Robin Carr, a renowned industry veteran who has worked at GSK and Astex, would head up and form a drug discovery advisory network in an effort to bolster the company's drug discovery capabilities.

The advisory network would bring together small molecule drug discovery and development experts from across the globe, harnessing industry expertise to build on C4XD's drug discovery capabilities and attract valuable relationships that had the potential to advance the C4X's goal of 'becoming the world's most productive drug discovery company,' the company said.

Through their extensive relationships and industry knowledge, Mr Carr and his team would identify pioneering complementary drug discovery technologies and collaborators that had the potential to accelerate or improve delivery of C4XD's portfolio, the company added.


At 9:32am: (LON:C4XD) C4x Discovery Holdings Plc share price was +0.5p at 39p



Story provided by StockMarketWire.com